Page last updated: 2024-08-21

plumbagin and Obesity

plumbagin has been researched along with Obesity in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Liang, D; Liu, L; Zhang, L1
Joshi, SG; Juvekar, AR; Martis, EAF; Munshi, RP; Pai, SA1
Gaur, IS; Gursahani, MS; Juvekar, AR; Mestry, SN; Munshi, RP; Pai, SA; Panchal, FH1

Other Studies

3 other study(ies) available for plumbagin and Obesity

ArticleYear
Plumbagin alleviates obesity-related asthma: Targeting inflammation, oxidative stress, and the AMPK pathway.
    Immunity, inflammation and disease, 2023, Volume: 11, Issue:9

    Topics: AMP-Activated Protein Kinases; Animals; Asthma; Cytokines; Humans; Inflammation; Male; Mice; Obesity; Oxidative Stress

2023
Plumbagin exerts antiobesity effects through inhibition of pancreatic lipase and adipocyte differentiation.
    Phytotherapy research : PTR, 2018, Volume: 32, Issue:8

    Topics: 3T3-L1 Cells; Adipocytes; Animals; Cell Differentiation; Humans; Kinetics; Lipase; Male; Mice; Molecular Docking Simulation; Naphthoquinones; Obesity; Plant Roots; Plumbaginaceae; Rats; Rats, Wistar; Triglycerides

2018
Plumbagin reduces obesity and nonalcoholic fatty liver disease induced by fructose in rats through regulation of lipid metabolism, inflammation and oxidative stress.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 111

    Topics: Adjuvants, Immunologic; Animals; Antioxidants; Fructose; Inflammation; Lipid Metabolism; Male; Naphthoquinones; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Random Allocation; Rats; Rats, Wistar

2019